CASE REPORT
Accepted on 10 Apr 2025
Case report: Combined PD-1 and tyrosine kinase blockade stabilizes refractory pancreatic cancer guided by the spatial structure of tumor immune microenvironment
doi 10.3389/fimmu.2025.1547388
- 166 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Response/Resistance to PD-1 Axis Inhibitors: Focus on the Tumor Microenvironment
Response/Resistance to PD-1 Axis Inhibitors: Focus on the Tumor Microenvironment
13k
Total downloads
35k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 11 Dec 2024
TLS and immune cell profiling: immunomodulatory effects of immunochemotherapy on tumor microenvironment in resectable stage III NSCLC
doi 10.3389/fimmu.2024.1499731
- 1,626 views
- 1 citation
REVIEW
Published on 03 Dec 2024
Leveraging the synergy between anti-angiogenic therapy and immune checkpoint inhibitors to treat digestive system cancers
doi 10.3389/fimmu.2024.1487610
- 753 views
- 1 citation
ORIGINAL RESEARCH
Published on 02 Dec 2024
PD-L2 act as an independent immune checkpoint in colorectal cancer beyond PD-L1
doi 10.3389/fimmu.2024.1486888
- 970 views
ORIGINAL RESEARCH
Published on 15 Oct 2024
PD-1 and CTLA-4 serve as major gatekeepers for effector and cytotoxic T-cell potentiation by limiting a CXCL9/10-CXCR3-IFNγ positive feedback loop
doi 10.3389/fimmu.2024.1452212
- 1,537 views
- 2 citations
CLINICAL TRIAL
Published on 23 Sep 2024
Opioid−free anesthesia attenuates perioperative immunosuppression by regulating macrophages polarization in gastric cancer patients treated with neoadjuvant PD-1 inhibitor
doi 10.3389/fimmu.2024.1438859
- 1,334 views
- 1 citation
ORIGINAL RESEARCH
Published on 28 Jun 2024
Training immunophenotyping deep learning models with the same-section ground truth cell label derivation method improves virtual staining accuracy
doi 10.3389/fimmu.2024.1404640
- 1,954 views
- 1 citation
CASE REPORT
Published on 31 May 2024
Successful treatment with tislelizumab plus chemotherapy for SMARCA4-deficient undifferentiated tumor: a case report
doi 10.3389/fimmu.2024.1371379
- 1,047 views
- 1 citation
ORIGINAL RESEARCH
Published on 11 Apr 2024
The predictive value of next generation sequencing for matching advanced hepatocellular carcinoma patients to targeted and immunotherapy
doi 10.3389/fimmu.2024.1358306
- 1,458 views
- 1 citation
REVIEW
Published on 10 Apr 2024
Potential application mechanism of traditional Chinese medicine in treating immune checkpoint inhibitor-induced colitis
doi 10.3389/fimmu.2024.1366489
- 1,810 views
- 1 citation
BRIEF RESEARCH REPORT
Published on 12 Mar 2024
Role of CD38 in anti-tumor immunity of small cell lung cancer
doi 10.3389/fimmu.2024.1348982
- 2,554 views
- 4 citations
REVIEW
Published on 07 Feb 2024
NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy
doi 10.3389/fimmu.2024.1342086
- 5,287 views
- 11 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore